Joshua Pinto - 21 May 2025 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
President
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Joshua Pinto
Issuer symbol
NMRA
Transactions as of
21 May 2025
Net transactions value
$0
Form type
4
Filing time
23 May 2025, 16:42:03 UTC
Previous filing
22 May 2025
Next filing
30 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pinto Joshua President C/O NEUMORA THERAPEUTICS, INC., 490 ARSENAL WAY, SUITE 200, WATERTOWN /s/ Michael Milligan, as Attorney-in-Fact for Joshua Pinto 23 May 2025 0001992595

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Gift $0 -13,202 -17% $0.000000 63,750 21 May 2025 Direct F1
transaction NMRA Common Stock Gift $0 +13,202 +9.5% $0.000000 152,167 21 May 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 21 2025, the Reporting Person transferred 13,202 shares of Common Stock to a family limited liability company (the "Family LLC") in a transaction exempt from reporting pursuant to Rule 16a-13. The Reporting Person continues to exercise investment control over the Common Stock held by the Family LLC.
F2 Shares held by Maple DE Holdings LLC, which is the entity defined above as "Family LLC".